Why that medicine you bought may not be real Health Just now
It offers a glimpse into a wider problem that Kenya’s drug regulator has now formally acknowledged: substandard and falsified medicines have already infiltrated the country’s regulated supply chain, and no one can say with certainty how many patients have been affected A regulator admits what many had suspected On July 1, the Pharmacy and Poisons Board (PPB) confirmed what many Kenyans and health experts had long suspected: that substandard and falsified medical products had been detected in pharmacies, health facilities and other licensed outlets.
Conducted by consultants Valérie Faillat and Epaphrodite Twahirwa of Mt Kenya University and published in a French pharmaceutical journal, the study found that 90 per cent of retail pharmaceutical outlets across all 85 Nairobi wards were selling at least one unauthorised parallel-imported medicine.
Of the 22 medicines examined, all failed at least one major regulatory requirement, and 90 per cent were missing the stated amount of active pharmaceutical ingredient per dosage unit, the batch number, the manufacturing and expiry dates, or the name and address of the marketing authorisation holder.
This is a summary of the original articles listed below. Always read the source articles for the full context. GhanaSummary does not create or modify the news — we summarise and link to original publishers.
